申请人:Enanta Pharmaceuticals, Inc.
公开号:US20170304272A1
公开(公告)日:2017-10-26
The present invention provides compounds of Formula I,
pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated as FXR modulators. Specifically, the present invention relates to isoxazole derivatives useful as agonists for FXR, and methods for their preparation and use.
本发明提供了化合物I的结构,包括这些化合物的药物组合物,并使用这些化合物治疗或预防作为FXR调节剂介导的疾病或疾病的方法。具体而言,本发明涉及用作FXR激动剂的异氧唑衍生物,以及其制备和使用的方法。